Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -0.26% | 87.92 | 1.3% | $848.13m | |
| BIIB | Biogen Inc. | 1.64% | 220.26 | 1.3% | $580.78m | |
| AMGN | Amgen Inc. | -0.06% | 186.59 | 1.2% | $533.06m | |
| ONCE | Spark Therapeutics, Inc. | 0.47% | 113.53 | 11.2% | $497.94m | |
| GILD | Gilead Sciences, Inc. | 0.03% | 63.79 | 0.9% | $468.70m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.82% | 395.00 | 2.6% | $283.62m | |
| ILMN | Illumina, Inc. | -1.65% | 303.71 | 3.5% | $275.40m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.28% | 183.85 | 1.9% | $247.78m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.73% | 118.92 | 15.4% | $216.64m | |
| BPTH | Bio-Path Holdings, Inc. | -12.42% | 19.25 | 190.1% | $203.41m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.60% | 132.29 | 2.0% | $187.73m | |
| EXAS | Exact Sciences Corporation | 0.07% | 89.06 | 25.3% | $173.12m | |
| A | Agilent Technologies, Inc. | 0.66% | 79.51 | 1.6% | $122.76m | |
| IONS | Ionis Pharmaceuticals, Inc. | 0.18% | 79.04 | 8.3% | $109.28m | |
| INCY | Incyte Corporation | 0.80% | 86.02 | 2.5% | $93.70m |
Company Profile
Insmed, Inc. operates as a biopharmaceutical company. It focus developing and commercializing inhaled therapies for patients battling serious lung diseases that are often life threatening. The firm develops and commercialization of ARIKAYCE or liposomal amikacin for inhalation for at least two identified orphan patient populations: patients with nontuberculous mycobacteria lung disease and cystic fibrosis patients with Pseudomonas aeruginosa lung infections. The company was founded in 1988 and is headquartered in Bridgewater, NJ.